Atlas Copco AB ATLAS COPCO A ORD .../ SE0017486889 /
2024-05-23 6:34:51 PM | Chg. +2.92 | Volume | Bid2024-05-23 | Ask2024-05-23 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
205.22SEK | +1.44% | 742,483 Turnover: 37.35 mill. |
-Bid Size: - | -Ask Size: - | 967.58 bill.SEK | 1.36% | 35.68 |
GlobeNewswire
1:45 PM
Victory Square Company Announces Access to Tirzepatide and GLP-1 Injections to its Weight Loss Portf...
GlobeNewswire
8:01 AM
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atla...
GlobeNewswire
05-22
Deepfence CNAPP Adds Runtime Protection and API Security for Generative AI Applications
GlobeNewswire
05-20
Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...
GlobeNewswire
05-14
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atla...
GlobeNewswire
05-13
Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire
05-06
Fortinet Threat Research Finds Cybercriminals Are Exploiting New Industry Vulnerabilities 43% Faster...
GlobeNewswire
04-25
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
04-25
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire
04-18
OpenDrives New Software-Defined Platform Atlas Wins 2024 NAB Show Product of the Year Award
GlobeNewswire
04-11
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
GlobeNewswire
04-10
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully ...